APOBEC3B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14542
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.81 mg/ml
Product Specifications
Immunogen
Synthetic peptide
Clonality
Polyclonal
Host
Rabbit
Description
Product can be stored undiluted at 4C for up to 1 month.
Scientific Data Images for APOBEC3B Antibody
Immunohistochemistry-Paraffin: APOBEC3B Antibody [NBP3-14542]
Immunohistochemistry-Paraffin: APOBEC3B Antibody [NBP3-14542] - Human Breast Carcinoma: Formalin-Fixed, Paraffin-Embedded (FFPE)Applications for APOBEC3B Antibody
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.1% Sodium Azide
Concentration
0.81 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Keep as concentrated solution. Aliquot and store at -20C or below. Avoid multiple freeze-thaw cycles.
Background: APOBEC3B
Alternate Names
APOBEC1L, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B, ARCD3, ARP4, bK150C2.2, cytidine deaminase, DJ742C19.2, EC 3.5.4, EC 3.5.4.-, FLJ21201, phorbolin 3, Phorbolin-1-related protein, Phorbolin-2/3, PHRBNLphorbolin 2, probable DNA dC->dU-editing enzyme APOBEC-3B
Gene Symbol
APOBEC3B
Additional APOBEC3B Products
Product Documents for APOBEC3B Antibody
Product Specific Notices for APOBEC3B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...